Biogen’s Apellis acquisition consolidates a complement franchise spanning retinal and renal indications, with near-term label ...

A 3-hour WHO Hantavirus emergency Zoom call was held this morning, providing outbreak analysis. It seemed that for every question asked many more questions were raised.

Dianthus Therapeutics is positioned as a category-expanding biotech, leveraging convenience and safety to address autoimmune neuromuscular and rheumatology markets. DNTH boasts a robust balance sheet ...

The complement system, a central arm of innate immunity, comprises a network of plasma and membrane-bound proteins that detect and eliminate pathogens. In severe COVID-19, SARS-CoV-2 triggers ...

The Chinook School Division says aggressive recruitment strategies and alternative pathways into classrooms are helping ...

Annexon (NASDAQ:ANNX) President and CEO Doug Love outlined the company's late-stage pipeline and regulatory plans during a presentation at the Bank of America Healthcare Conference, highlighting ...

An annual psychiatric meeting was abuzz over Robert F. Kennedy Jr.’s call to rein in the use of depression medications. Some ...

Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the first quarter 2026 on ...

NPS Swasthya complements traditional health insurance by creating an additional healthcare-focused financial cushion within ...

Strategic partnership expands access to women-focused privacy garments supporting dignity, comfort, and trauma-informed ...

***Money is not a client of any investment adviser featured on this page. The information provided on this page is for educational purposes only and is not intended as investment advice. Money does ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune disease ...